What Does It Take to Develop Structurally Complex Molecules by Total Synthesis? Rapid Process Development and GMP Manufacturing of E7130 Drug Substance for First-in-Human Clinical Study

MLA

Sasaki, Takeo, et al. “What Does It Take to Develop Structurally Complex Molecules by Total Synthesis? Rapid Process Development and GMP Manufacturing of E7130 Drug Substance for First-in-Human Clinical Study.” Organic Process Research & Development, vol. 28, no. 6, June 2024, pp. 2077–89. EBSCOhost, https://doi.org/10.1021/acs.oprd.4c00016.

APA

Sasaki, T., Yahata, K., Isomura, M., Ohashi, I., Fukuyama, T., Miyashita, Y., Watanabe, Y., Murai, N., Matsuda, M., Kamada, A., Kaburagi, Y., Kira, K., Iso, K., Sato, Y., Matsuura, F., Matsumoto, Y., Azuma, H., Iida, D., Ishida, T., … Kishi, Y. (2024). What Does It Take to Develop Structurally Complex Molecules by Total Synthesis? Rapid Process Development and GMP Manufacturing of E7130 Drug Substance for First-in-Human Clinical Study. Organic Process Research & Development, 28(6), 2077–2089. https://doi.org/10.1021/acs.oprd.4c00016

Chicago

Sasaki, Takeo, Kenzo Yahata, Minetaka Isomura, Isao Ohashi, Takashi Fukuyama, Yusuke Miyashita, Yuzo Watanabe, et al. 2024. “What Does It Take to Develop Structurally Complex Molecules by Total Synthesis? Rapid Process Development and GMP Manufacturing of E7130 Drug Substance for First-in-Human Clinical Study.” Organic Process Research & Development 28 (6): 2077–89. doi:10.1021/acs.oprd.4c00016.